Page last updated: 2024-08-24

arctigenin and Cancer of Lung

arctigenin has been researched along with Cancer of Lung in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Cao, J; Chen, YF; He, QJ; Liu, RZ; Shao, XJ; Xiang, SF; Yang, B; Yang, YN; Ying, MD; Ying, WW; Zhang, YQ1
An, H; Chen, Y; Guo, S; Shi, S; Wang, X; Zhan, Y; Zhang, H1
Lee, SH; Lou, Z; Xu, Y1
Inafuku, M; Iwasaki, H; Oku, H; Susanti, S; Taira, N1
Jin, JJ; Wang, HQ; Wang, J1
Choi, BM; Han, YH; Hong, SH; Jeong, MY; Kee, JY; Kim, DS; Kim, HJ; Mun, JG; Park, SH; Park, SJ; Um, JY1

Other Studies

6 other study(ies) available for arctigenin and Cancer of Lung

ArticleYear
Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:3

    Topics: Apoptosis Regulatory Proteins; Cullin Proteins; Furans; Humans; Lung Neoplasms; NEDD8 Protein; RNA-Binding Proteins; Ubiquitin-Conjugating Enzymes

2023
Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy.
    Pharmacological research, 2020, Volume: 155

    Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Antineoplastic Agents; Cell Line; Furans; Humans; Lignans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C

2020
Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells.
    Biochemical and biophysical research communications, 2017, 11-18, Volume: 493, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Asteraceae; beta Catenin; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Furans; Humans; Lignans; Lung; Lung Neoplasms; Neoplasm Invasiveness; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta

2017
Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Dec-15, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Apoptosis; Arctium; Cell Cycle Proteins; Cell Line; Cyclin E; Cyclin-Dependent Kinase 2; Cyclins; Down-Regulation; Furans; Glutathione; Humans; Lignans; Lung Neoplasms; Nuclear Proteins; Oncogene Proteins; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Signal Transduction

2013
Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
    Journal of biochemical and molecular toxicology, 2014, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Base Sequence; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cisplatin; DNA Primers; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Furans; Humans; Inhibitor of Apoptosis Proteins; Lignans; Lung Neoplasms; Polymerase Chain Reaction; Survivin

2014
Arctigenin Inhibits Lung Metastasis of Colorectal Cancer by Regulating Cell Viability and Metastatic Phenotypes.
    Molecules (Basel, Switzerland), 2016, Aug-27, Volume: 21, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Female; Furans; Lignans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis

2016